Document is current
Any future updates will be listed below
-
Authors
Jiang, Yan
Zeng, Yuhong
Xin, Li
Chen, Wei
Xu, Youjia
Tian, Shoujin
Wang, Qinglai
Li, Jianjun
Chen, Shihong
Lin, Xuanxia
Ying, Qifeng
Chiba, Shun
Yamagiwa, Chiemi
Yamaguchi, Tomohiro
Ke, Zheng
Xia, Weibo
Takeuchi, Yasuhiro
- License Information
-
More Information
Article History
Received: 23 December 2025
Accepted: 12 May 2026
First Online: 16 June 2026
Declarations
:
: Shun Chiba, Chiemi Yamagiwa and Tomohiro Yamaguchi are employees of Chugai Pharmaceutical Co., Ltd. Zheng Ke is an employee of Chugai Pharma China Co., Ltd. Weibo Xia received consulting fees from Chugai Pharmaceutical Co., Ltd. and payments for lectures and presentations from Chugai Pharmaceutical Co., Ltd. Yasuhiro Takeuchi received consulting fees from Chugai Pharmaceutical Co., Ltd. and payments for lectures and presentations from Chugai Pharmaceutical Co., Ltd., Teijin Pharma Ltd., Daiichi-Sankyo Inc., Amgen Inc., Astellas Pharma Inc., and Asahi Kasei Pharma Corp.
: The study protocol and associated documents were approved by Independent Ethics Committees at each study site before starting the study. Written informed consent was provided by the patient or the patient’s legally acceptable representative before study participation.
